About Us

Founded in 2018, Rinri Therapeutics Ltd. is a therapeutic discovery and development company working in the field of hearing loss supported by Boehringer Ingelheim Venture Fund and UCB Ventures, BioCity and The University of Sheffield.

Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.

The Company has a team of experienced management, strong academic pedigree and excellent potential for clinical development.

Latest News

People

Dr. Erica Whittaker

Investor Director & Chair
Erica began her career at UCB in 2010 as VP Strategy & Partnering where she developed and led the UCB-Harvard Research Alliance More

Frank Kalkbrenner

Investor Director

Frank is the Global Head of the Boehringer Ingelheim Venture Fund. More

Dr. Claire Brown

Investor Director

Claire currently leads BioCity’s investment activity making seed-stage investments into early life Science and healthcare companies. More

Ross McMaster

Investor Director
Ross joined Sheffield University Enterprise Ltd. (SUEL) in 2003 having started his career in both local and national chartered accountancy practices. More

Prof. Marcelo Rivolta

Founder Director

Marcelo is a globally recognised thought leader in the field of sensory stems cells authoring over 40 papers in the field including publishing in Nature. More

Dr. Simon Chandler

CEO

Simon has deep sector knowledge and in-depth experience of the biotech sector. More

Ms Danielle Thompson

Finance & Business Support
Danielle has provided administration and accounting support to Rinri since the company’s formation. More